Molina Healthcare (MOH) Cash & Equivalents (2010 - 2026)

Molina Healthcare has reported Cash & Equivalents for 17 years, with the latest figure at $5.0 billion in Q2 2026.

• Quarterly Cash & Equivalents rose 10.8% year-over-year to $5.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.0 billion (up 10.8% YoY) and the FY2025 annual result came in at $4.2 billion, down 8.88% from the prior year.
• Cash & Equivalents fell to $5.0 billion in Q2 2026 per MOH's latest filing, from $5.3 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $5.6 billion in Q3 2023 and troughed at $4.0 billion in Q4 2022.
• A 5-year average of $4.6 billion and a median of $4.6 billion in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents jumped 31.19% in 2023, then retreated 14.97% in 2024.
• Over 5 years, Cash & Equivalents stood at $4.0 billion in 2022, then climbed by 21.02% to $4.8 billion in 2023, then slipped by 3.84% to $4.7 billion in 2024, then declined by 8.88% to $4.2 billion in 2025, then gained by 17.35% to $5.0 billion in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $5.0 billion, $5.3 billion, and $4.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.